Coupling Genetic Addiction Risk Score (GARS) and Pro Dopamine Regulation (KB220) to Combat Substance Use Disorder (SUD)
Somchai Amornyotin*
Department of Anesthesiology and Siriraj Gl Endoscopy Center,Thailand
Submission: February 21, 2017; Published: March 27, 2017
*Corresponding author: Somchai Amornyotin, MD, FRCAT, Associate Professor of Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Bangkok 10700, Thailand, Tel: 6624197990; Email:somchai.amo@mahidol.ac.th
How to cite this article: Somchai A. Anesthesia Innovation: Mini-Review of an Intravenous Sedation for Gastrointestinal Endoscopy. Adv Res Gastroentero Hepatol 2017; 4(3): 555636. DOI: 10.19080/ARGH.2017.04.555636
Abstract
Gastrointestinal endoscopy (GIE) is a procedure for diagnosis and treatment of gastrointestinal tract abnormalities. To date, intravenous sedation is commonly used for this procedure. The new sedative drugs and equipment for safety and efficacy are available. This mini-review focuses on innovation in intravenous sedation (IVS) for GIE procedures.
Keywords: Innovation; Intravenous Sedation; Gastrointestinal Endoscopy
Abbreviations: IVS:Intravenous Sedation; GIE: Gastrointestinal Endoscopy; TCI: Target-Controlled Infusion; PCS: Patient-Controlled Sedation; CAPS: Computer-Assisted Personalized Sedation
Introduction
Intravenous Sedation (IVS) is one of the important components of gastrointestinal endoscopic (GIE) procedures. The aim of sedation for these procedures is to improve patient's comfort and endoscopic practice as well as patient and endoscopist satisfaction. The depth of sedation level is dependent on the type and duration of endoscopy, experience of endoscopist, and patient's physical status. The sedation regimens for GIE procedures are quite different. To date, several sedation techniques are utilized. The new sedative drugs and equipment for safety and efficacy are available [1-4].
Target-Controlled Infusion
Target-controlled infusion (TCI) is a sophisticated tool for providing optimal sedation regimen avoiding under or over sedation in GIE procedures. This technique uses a pharmacokinetic model to predictthe patient plasma and effect site concentrations from the infusion design and allows the anesthesiologist to target a selected concentration. The device computes the appropriate infusion system to achieve this concentration [5]. The TCI rapidly accomplishes and maintains a predefined plasma or effect site concentration of the anesthetic drug. Presently, TCI devices for propofol administration are approved in several countries. A previous study determined the quality and plausibility of TCI as a sedation mechanism for upper and lower GIE procedures.This study confirmed that TCI sedation for GIE provided safe and effective sedation and was associated with a better sedation quality [6]. Wang and colleagues evaluated whether TCI of propofol could offer a better sedation quality than manually controlled infusion in training inexperienced anesthesiology residents. The authors concluded that TCI was a more effective and safer technique for anesthesiology residents in sedation for colonoscopy [7].
Patient-Controlled Sedation
Patient-controlled sedation (PCS) usually involves a targetcontrolled method. There are two types of PCS. In open-loop system, the sedation is adjusted according to a target drug concentration. In closed-loop system, the patient directs the infusion system to release medication up to a set point. A systematic review and meta-analysis assessed the advantages and disadvantages between PCS and traditional IVS. The review demonstrated that PCS was as feasible and effective as traditional IVS for colonoscopy. PCS relatively shows its superiority in recovery time, incidence for oxygen saturation and hypotension [8]. Recently, PCS is readily implemented in clinical practice. It is suitable for IVS in younger and low-risk patients and is associated with less cardio respiratory adverse effects [9]. Adding propofol to remifentanil or alfentanil increases sedation, and potentiates analgesia, with no increase in respiratory depression. The combination regimen is a safe and feasible method for PCS [10].
A prospective, randomized, controlled study compared the use of PCS with propofol and remifentanil and the anesthesiologist- administered propofol sedation for 80 elective endoscopic patients. All patients were completely successful except two patients in the PCS group. Mean level of sedation and total propofol requirement in the PCS group were significantly lower than in the anesthesiologist- administered propofol group. The study confirmed that PCS with propofol and remifentanilwas a safe and well-accepted sedation technique for endoscopic patients [11]. Moreover, time to sedation and the recovery time in the PCS with the propofol and remifentanil group were significantly shorter than in the PCS with the fentanyl and midazolam group. However, the perceptions of patients, nurses and endoscopists were comparable between the two groups [12].
Computer-Assisted Personalized Sedation
Computer-assisted personalized sedation (CAPS) is a sedation delivery system to administer propofol. It is based on thepatient response to stimulation and physiologic profiles. It presents an attractive means ofdelivering safe and effective doses of propofol. The closed-loop target-controlled system orcontinuous electroencephalographic recordings are used to assess the depth of sedation. Patient-controlledplatforms may also be used. These devices may help physicians titrating propofol administrationand controlling the physiological functions. The American Society for Gastrointestinal Endoscopy Technology Committee provides reviews of this system that have the potential to have an impact on the practice of GIE [13]. Several previous studies demonstrated the feasibility of CAPS for facilitating the accurate administration of propofol by endoscopist or nurse teams, achieving minimal to moderate sedation in patients undergoing routine GIE procedures. Mean propofol dosage was low and post-procedure recovery time was rapid [14].
The SEDASYS System is a CAPS device that delivers the drug propofol for minimal-to-moderate sedation. The device provides comprehensive patient monitoring and limits the depth of sedation by adjusting drug delivery accordingly. The efficacy and safety of this system for sedation during GIE procedures was evaluated and compared with the combination of benzodiazepineand opioid in adult patients with ASA physical status class I-III. All patients were sedated in mild to moderate depth of sedation level. The study confirmed that SEDASYS system was safe and effective for sedation during GIE procedures. Patient and physician satisfaction as well as recovery time in the SEDASYS group were significantly better than in the combination of benzodiazepine and opioid group [15]. The use of CAPS system by non-anesthetic personnel for mild or moderate sedation in GIE patients was also safe and effective [14].
Conclusion
GIE procedure requires some forms of anesthesia. IVS is commonly used for this procedure. Sedation could be effectively and safely performed by anesthesiologist or non-anesthetic personnel with appropriate patient selection and monitoring. The new sedative drugs and equipment are available. However, preanesthetic assessment and preparation, anesthetic drugs used, monitoring practices and post-anesthesia management are still essential for the anesthesia innovation in GIE procedures.
Conflict of Interest
No financial support was received for the preparation of this study. The author declares that no conflict of interest exists.
References
- Amornyotin S (2015) Anesthesia innovations for endoscopy of gastrointestinal tract. In: Amornyotin S, editor. Endoscopy-Innovative Uses and Emerging Technologies In Tech, pp. 39-61.
- Amornyotin S (2016) Intravenous sedation techniques for gastrointestinal endoscopy. J Gastroenterol Hepatol Res 5(3): 20502057.
- Amornyotin S (2014) Sedative and analgesic drugs for gastrointestinal endoscopic procedure. J GastroenterolHepatol Res 3(6): 1133-1144.
- Amornyotin S (2013) Sedation and monitoring for gastrointestinal endoscopy. World J Gastrointest Endosc 5(2): 47-55.
- GuARGHacino F, Lapolla F, Cariello C, Danella A, Doroni L, et al. (2005) Target controlled infusion: TCI. Minerva Anestesiol 71(6): 335-337.
- Chang YT, Tsai TC, Hsu H, Chen YM, Chi KP, et al. (2015) Sedation for gastrointestinal endoscopy with the application of target-controlled infusion. Turk J Gastroenterol 26(5): 417-422.
- Wang JF, Li B, Yang YG, Fan XH, Li JB, et al. (2016) Target-controlled infusion of propofol in training anesthesiology residents in colonoscopy sedation: a prospective randomized crossover trial. Med Sci Monit 22: 206-210.
- Lu Y, Hao LX, Chen L, Jin Z, Gong B (2015) Systematic review and meta-analysis of patient-controlled sedation versus intravenous sedation for colonoscopy. Int J Clin Exp Med 8(11): 19793-19803.
- Jokelainen J, Udd M, Kylanpaa L, Mustonen H, Halttunen J, et al. (2017) How patient-controlled sedation is adopted in clinical practice of sedation for endoscopic retrograde cholangiopancreatography? A prospective study of 1196 cases. Scand J Gastroenterol 52(2): 166-172.
- Sultan SS (2014) Patient-controlled sedation with propofol/ remifentanil versus propofol/alfentanil for patients undergoing outpatient colonoscopy, a randomized, controlled double-blind study. Saudi J Anesth 8(Suppl 1): 36-40.
- Mazanikov M, Udd M, Kylanpaa L, Lindstrom O, Aho P,et al. (2011) Patient-controlled sedation with propofol and remifentanil for ERCP: a randomized, controlled study. Gastrointest Endosc 73(2): 260-266.
- Mandel JE, Tanner JW, Lichtenstein GR, Metz DC, Katzka DA, et al. (2008) A randomized, controlled, double blind trial of patient-controlled sedation with propofol/remifentanil versus midazolam/fentanyl for colonoscopy. Anesth Analg 106(2): 434-439.
- Banerjee S, Desilets D, Diehl DL, FARGHaye FA, Kaul V, et al. (2011) Computer-assisted personalized sedation. Gastrointest Endosc 73(3): 423-427.
- Pambianco DJ, Whitten CJ, Moerman A, Struys MM, Martin JF (2008) An assessment of computer-assisted personalized sedation: a sedation delivery system to administer propofol for gastrointestinal endoscopy Gastrointes Endosc 68(3): 542-547.
- Pambianco DJ, Vargo JJ, Pruitt RE, Hardi R, Martin JF (2011) Computer- assisted personalized sedation for upper endoscopy and colonoscopy: a comparative, multi center randomized study. Gastrointest Endosc 73(4): 765-772.